Stryker Licenses ArthroCare Coblation Technology Following Serfas Launch
This article was originally published in The Gray Sheet
Executive Summary
Stryker Corp. agreed to license ArthroCare's Coblation radiofrequency arthroscopy technology just days after its mid-June launch of the competing Serfas arthroscopy product in order to head-off a patent infringement suit, ArthroCare says.
You may also be interested in...
Cygnus Sizzles In June; Stock Rises 77% On Heels Of Diabetes Conference
The stock prices of diabetes product manufacturers Cygnus and MiniMed headed in opposite directions in the aftermath of the June 9-13 annual meeting of the American Diabetes Association.
Cygnus Sizzles In June; Stock Rises 77% On Heels Of Diabetes Conference
The stock prices of diabetes product manufacturers Cygnus and MiniMed headed in opposite directions in the aftermath of the June 9-13 annual meeting of the American Diabetes Association.
ArthroCare v. Ethicon
Under an agreement to settle ArthroCare's February 1998 patent infringement suit against Ethicon and subsidiaries Mitek and Gynecare, Ethicon will pay ArthroCare a license fee and ongoing royalties on ArthroCare's U.S. patents in the arthroscopy and gynecology markets, ArthroCare announces June 24. Additional terms of the settlement were not disclosed